Document LJMd7yMZ5NZ3Zd5vM0y78R9Gw

SRoei:e e pmo- ieear . r Bam ---.. emaapr0 thedela but wea vary buyin eid LoeegCoavleroemd3byDehceemebxeermptthiodnesriongAatriioncw4l2.a1npaanldctahelg.enAeraslolmeastohr PnFeOwAdweillegaatpe.d cTthenptrordsucitswfiolrcle.the mSliowled deviecnesFiOlRbeiacboovvereedtebcrehsnoolwdoUfTC2a55.thee manufacturing pacing o he marke andusewil be iNamtpiloannatlabaluetmehdoircaslrdeirceespcoonntsaiinifnog asunbfsotracnacmeasntbealnodwtUhTeCy awielibnefcoorvmeerdetdhaotannonbnytahseivnewanddelnegnated ac We have included is pit or discussion at th POP CAs meetingof ertweek. -- Regards FSreontm::TI esi, November 17,@2m0e2d0te1c5he7urope.org Tpoo env -- EE -- T`DSubijeect:sKGiennfdtrleemrienmdienrdetrh:atAwmeenwdomeuntveorfy tmhuecEhUaPpOpPrescRieagtuelaatrieosnporensPeF0OAhreestmreisctsiaogne of below: OMuanmyemhbarekrssfoarreyowuorrteefdorhs inadeoaltiuSngtwaitttohni rewqueesatv.ete eT 2500 2 BOI: Setwishes. - FSreonm: rida. 13 November 20200920 Tpoo @cceurops.v INI -- `eMSasubnrjye[cht:aSnREk:s.Gfeonrtyloeurrermeisnpdoenrs:eAs.mendment of the EU POPs Regulation: Follow-upon PFOA restriction Taheatdwoonth mleaatnesatdaevmeilnoipmmuemntsse,vermaelawnesektshoatfPgataiamSeenttwaenedn 3CoDeucnecmbhaevreannidlh2e3uJammaary abc. Cpouublidcaytoounpaenrdhaapnsedanrtoywfhoarohfcatphepeanmsedndmeunth.art apiperinod? STheactwwisohes,amos etl llr Regiations and industrial Ply from: nines Medtech Europe 8 @ec.europa.eu Sent: Thursday, 12 November 2020 17:42 To: @medtecheurope.org> Cc: Subject: RE: Gentle reminder: Amendment of the EU POPs Regulation: Follow-up on PFOA restriction Dear I just received the confirmation that the adoption of the amendment is scheduled for 23 November. Regards From: (ENV) Sent: Thursday, November 12, 2020 5:32 PM To: @medtecheurope.org> Cc: Subject: RE: Gentle reminder: Amendment of the EU POPs Regulation: Follow-up on PFOA restriction Dear The internal procedure for launching the adoption via written procedure is not concluded yet. The adoption should be launched in the upcoming days, and then it takes normally less than one week for the adoption. This amendment is a Commission delegated act: https://ec.europa.eu/info/law/law-makingprocess/adopting-eu-law/implementing-and-delegated-acts_en After the Commission adoption, the Parliament and the Council will have 2 months for the right of objection. If they do not object, the amendment is published and it enters into force. Then, the most likely situation is that on 3 December the act is adopted but not yet published. We will most probably raise this in the upcoming POPs CAs meeting. Regards From: @medtecheurope.org> Sent: Monday, November 9, 2020 9:21 AM To: (ENV) Cc: Subject: RE: Gentle reminder: Amendment of the EU POPs Regulation: Follow-up on PFOA restriction Dear , Further to our exchanges of below, I am coming back to you to request some clarifications regarding the proposed amendment of the POP regulation for PFOA. In particular, it would be very helpful to know if you see the possibility for the amendment to be published within the next weeks. The current derogation will be applicable until 3rd December and it would be important for us to know if the amendment will be in place until this time. Unfortunately the timeline for the adoption procedure is not really clear to me. Does it mean that the Commission only have to get the internal approvals and then the adoption will be published immediately? Or do the Parliament and the Council have two months to formulate any objections after the internal approval and then the amendment enters into force? In case the publication depends only on the internal approval at Commission level, we would appreciate if you could highlight the urgency in your department since the current derogation will end on 3rd December. It would be most useful if you can clarify the above as our members have started to ask questions and we may be getting more in the next period. Looking forward to your feedback. Best wishes, orRegions and industrial Ply or Rates Medtech Europe a Sent: Wednesday, 28 October 20201233 "wYSou@:beIcNt: E.G re mi nd :medtecheurope.org> er: Amendment of th EU OPs Regain: F ol lo wuopn Fro esicion Weare s|tl aiing fo al ner approvals launch he adoption procedure. We Knexopewctwhhaetn tthhearmoecneddmuernetssuhunldcbs aanddopted hethn buepacbolmeitngewseteikmsa.tetihl mlynoue mRoeregpaoche. TL FSreonmt:I Wednesday, October 28N ,2m0e2dt0e1c0he3u7rAonMe.org Tpoo en SPurbolncr:etGiecntiloenreminder: Amendmoefnhte 0 FOP Regulation: Flopwon importance: High LcaomrIwrRiNn0g.remind youthatwe would asrecate 3 responstoethe uestions OuofrbeCohenm.icals WG meetiintodayat 14800 and would eb ges 0 beable to Iprnovaidre tahe,mweembweorlsdwibethkheeete0Kstnoupwdawtheesn.thadoptionofth delegated ack Tihganhk tyaokeunlaacea.nce sestwishes, Re]gulations and industrial Policy seo:I jMee"dnTsecchiEuaronpecnss = `TSSooern2t:01We0d5n0esday, 14 October = ceuropsv I Sublet Amendmentof th EU POP Regulation: Follow-aunp POArestriction Importance: igh oc11aarmmItnhoewNswrui.ncgycooufetI ofsoNsloN lroonawnJd-REjuoipnedpMreedvTioeucsheExucrhaonpgeersecweintthlyy.ou on PCoFuOlAdaynoduoKnintdlhyeesttamteemkenntowsiuftbmhietrteedhbayveusbeiennsuamnymdeerv-ealtotpamcehnetds.at the oCfomoumriCshseimoincaolnstWisGflie aconmifnogusrovoinewasndhmaevmbbeeernscaoensvirdeyrkeede?nThteo nheexatrmseoemteing Aulptdeartneatsiovenlythwiseicssaune.also have direct discussion by phoneifthats more Lcoonovkeinnigefnotrfwoarrdyotuo.you feedback. Best wishes, smoedecheutonreg MedTech Europe | |